EUVIMEDEUVIMED entdecken
Qualitative Studie

Barriers to Effective Treatment of Genitourinary Syndrome of Menopause: A Qualitative Study on Patient Perspectives on Vaginal Estrogen

Helen Y Zhang iD, Sarah E Andiman, Antonella M D'Ascanio, Cara L Grimes, Dominique Malacarne Pape

International Urogynecology Journal · 2025

DOI: 10.1007/s00192-025-06246-3 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Helen Y Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Georgetown University/MedStar Washington Hospit…. Hauptthemen laut MEDLINE: Menopause, Estrogens, Female Urogenital Diseases, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND HYPOTHESIS: Vaginal estrogen therapy is widely accepted as a safe and effective treatment for symptoms of genitourinary syndrome of menopause (GSM), yet it is likely underutilized owing to various factors relating to patient perceptions, barriers to access, and health care system outreach. The aim of our study is to explore patient beliefs and opinions regarding its use. METHODS: A qualitative study was conducted with patients prescribed vaginal estrogen at an ambulatory urogynecology office between October 2022 and August 2023. Participants completed a symptom inventory followed by a 1:1 in-depth interview based on a structured guide designed to elicit candid insights and detailed responses into perceptions and experiences with vaginal estrogen. Data were analyzed using grounded theory methods in a three-phase coding process to identify key themes. RESULTS: Twenty-two participants were interviewed. Six major themes emerged: knowledge base, barriers to health care access, motivation for symptom relief, concerns regarding side effects, physician-patient relationship, and barriers to compliance. Although participants understood the connection between GSM and aging, they often felt unclear about which symptoms vaginal estrogen targeted, how to apply it, and how it differed from systemic hormone replacement therapy. Barriers such as cost, lack of insurance coverage, and concerns about cancer were frequently reported. Physician education helped to alleviate fears, improving patient confidence in using vaginal estrogen. CONCLUSIONS: This study identified key beliefs and barriers affecting the use of vaginal estrogen for GSM. These findings highlight the need for improved patient education, better physician counseling, and enhanced communication to support adherence to this beneficial therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MenopauseEstrogensFemale Urogenital DiseasesHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityEstrogen Replacement TherapyHumansFemaleQualitative ResearchMiddle AgedAdministration, IntravaginalAgedSyndromePhysician-Patient RelationsAdult

Stichwörter der Autor:innen

EstrogenGenitourinary syndrome of menopauseHormonesMenopauseVaginal atrophy

Substanzen

Estrogens

Autor:innen und Institutionen

  • Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Georgetown University/MedStar Washington Hospital Center, 106 Irving Street NW Suite 405, Washington, DC, 20010, USA.…
  • Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
  • New York Medical College, Valhalla, NY, USA.
  • Department of Obstetrics and Gynecology, Albany Medical Center, Albany, NY, USA.
  • Department of Obstetrics and Gynecology, Westchester Medical Center, Hawthorne, NY, USA.
  • Department of Urology, New York Medical College, Valhalla, NY, USA.

ORCID-Profile: Helen Y Zhang

Zitieren

APA

Zhang, H. Y., Andiman, S. E., D'Ascanio, A. M., Grimes, C. L., & Pape, D. M. (2025). Barriers to Effective Treatment of Genitourinary Syndrome of Menopause: A Qualitative Study on Patient Perspectives on Vaginal Estrogen. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06246-3

Vancouver

Zhang HY, Andiman SE, D'Ascanio AM, Grimes CL, Pape DM. Barriers to Effective Treatment of Genitourinary Syndrome of Menopause: A Qualitative Study on Patient Perspectives on Vaginal Estrogen. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06246-3

BibTeX
@article{Zhang2025,
  author = {Zhang, Helen Y and Andiman, Sarah E and D'Ascanio, Antonella M and Grimes, Cara L and Pape, Dominique Malacarne},
  title = {Barriers to Effective Treatment of Genitourinary Syndrome of Menopause: A Qualitative Study on Patient Perspectives on Vaginal Estrogen},
  journal = {International Urogynecology Journal},
  year = {2025},
  doi = {10.1007/s00192-025-06246-3}
}
Kostenlos starten →